Status:
COMPLETED
CPAP in Diabetes Type 2 Patients With Sleep Apnea
Lead Sponsor:
Hospital Universitario La Paz
Conditions:
Diabetes
Sleep Apnea
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Aim: To assess if six months of treatment with CPAP associated with conventional drug therapy, contribute to improved glycemic control in patients with type 2 diabetes and sleep apnea-hypopnea syndrom...
Detailed Description
Main objective: To assess the effect of 6 months of CPAP treatment associated with conventional drug therapy on glycemic control in patients with type 2 diabetes and sleep apnea-hypopnea syndrome (SA...
Eligibility Criteria
Inclusion
- subjects 18 to 75 years old; diagnosis of type 2 diabetes mellitus; treatment with diet; oral antidiabetics or insulin stable in the last month; levels of HbA1c\> 7.5% (if not supported clinic two controls to confirm with a difference not exceeding 0.5%); overweight or obese (BMI ≥ 25 kg/m2)
Exclusion
- professional drivers, risk profession or respiratory failure; excessive daytime sleepiness is very high (Epworth scale\> 18); morbid obesity (BMI\> 40 kg/m2); CPAP treatment
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT01801150
Start Date
October 1 2011
End Date
January 1 2015
Last Update
March 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario La Paz- IdiPaz
Madrid, Madrid, Spain, 28046